As shown in Fig. 3h, NMDAR1-AB seropositive APOE4 carriers (N = 34; permeable BBB [51–53]) had significantly lower depression and anxiety ratings as compared with all controls (N = 1013) that do not combine both markers (APOE4+ and NMDAR1-AB+). This evidence concerns the gene APOE and depressive symptom measurement.